<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02308839</url>
  </required_header>
  <id_info>
    <org_study_id>FPR12-02</org_study_id>
    <nct_id>NCT02308839</nct_id>
  </id_info>
  <brief_title>GORE® EXCLUDER® Endprosthesis French Mandatory Registry</brief_title>
  <official_title>Study of the GORE® EXCLUDER® Endoprosthesis in the Treatment of Infra-renal Abdominal Aortic Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>W.L.Gore &amp; Associates</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>W.L.Gore &amp; Associates</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a French Registry mandated by the French National Health Authority assessing
      long-term (5-years) safety of the GORE® Excluder® Endoprosthesis in the treatment of
      infra-renal Abdominal Aortic Aneurysms (AAA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of abdominal aortic endoprostheses makes the treatment of infra-renal abdominal
      aortic aneurysms possible, with implantation via the femoral artery, thus avoiding a very
      invasive surgical procedure. The French National Authority for Health requires a 5-year
      follow-up as part of the renewal for reimbursement for these endprostheses.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Overall mortality rate</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality rate related to the aneurysm</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Aneurysm diameter growth</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Endoleak rate (Type I, II and III)</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Migration rate</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of surgical conversion</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of endovascular or surgical re-intervention</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <enrollment type="Actual">181</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GORE® EXCLUDER® Endoprosthesis</intervention_name>
    <description>Endovascular therapy to treat abdominal aortic aneurysms</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients requiring treatemtn with an endoprosthesis for the treatment of an unruptured
        infra-renal aortic abdominal aneurysm.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patients requiring abdominal aortic stenting for the treatment of an unruptured
             infra-renal aortic abdominal aneurysm.

        Exclusion Criteria:

          -  Patients whose clinical follow-up is not possible, i.eg, patient who cannot return for
             control visits (e.g. patients living abroad).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Steinmetz, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire du Bocage</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier de Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21034</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2014</study_first_submitted>
  <study_first_submitted_qc>December 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2014</study_first_posted>
  <last_update_submitted>September 26, 2017</last_update_submitted>
  <last_update_submitted_qc>September 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aneurysm</keyword>
  <keyword>Aorta</keyword>
  <keyword>Abdominal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

